<PAGE>



               UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C. 20549

                                  FORM 10-QSB

(x)      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

               For the quarterly period ended September 30, 2003

(  )     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

    For the transition period from __________________to __________________

                        Commission File Number 0-29057

                         ALTRIMEGA HEALTH CORPORATION
                         ----------------------------
              (Exact name of registrant as specified in charter)

<TABLE>
<S>                                                                              <C>

                            Nevada                                                       87-0631750
                            ------                                                       ----------
(State or other jurisdiction of incorporation or organization)                   (I.R.S. Employer I.D. No.)

             4702 Oleander Drive, Suite 200, Myrtle Beach, SC                                     29577
             ------------------------------------------------                                     -----
                 (Address of principal executive offices)                                         (Zip)

                       Issuer's telephone number, including area code                (843) 497-7028
                                                                                     --------------

         Check  whether the issue (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exhcnage  Act during the past 12 months (or for such
shorter  period that the  registrant  was required to file such reports) and (2)
has been subject to such filing requirements for the past 90 days.

                              Yes /x/    No / /

                              Securities registered pursuant to section 12 (b) of the Act:

                     Title of each class                                 Name of each exchange on which registered
                             None                                                          None
                             ----                                                          ----

                              Securities registered pursuant to section 12 (g) of the Act:

                                        Common Stock, par value $0.001 per share
                                        ----------------------------------------
                                                    (Title of Class)

          As of November 17, 2003, the Company had 48,139,950 shares of common stock issued and outstanding.

</TABLE>

         Transitional Small Business Disclosure Format  (check one).
                                                  Yes  [ ]   No  [X]


<PAGE>




                          PART I: FINANCIAL INFORMATION


                                INTRODUCTORY NOTE


FORWARD-LOOKING STATEMENTS

         This Form 10-QSB contains "forward-looking statements" relating to
Altrimega Health Corporation ("Altrimega") which represent Altrimega's current
expectations or beliefs including, but not limited to, statements concerning
Altrimega's operations, performance, financial condition and growth. For this
purpose, any statements contained in this Form 10-QSB that are not statements
of historical fact are forward-looking statements. Without limiting the
generality of the foregoing, words such as "may", "anticipation", "intend",
"could", "estimate", or "continue" or the negative or other comparable
terminology are intended to identify forward-looking statements. These
statements by their nature involve substantial risks and uncertainties, such
as credit losses, dependence on management and key personnel, variability of
quarterly results, and the ability of Altrimega to continue its growth
strategy and competition, certain of which are beyond Altrimega's control.
Should one or more of these risks or uncertainties materialize or should the
underlying assumptions prove incorrect, actual outcomes and results could
differ materially from those indicated in the forward-looking statements.

         Any forward-looking statement speaks only as of the date on which
such statement is made, and Altrimega undertakes no obligation to update any
forward-looking statement or statements to reflect events or circumstances
after the date on which such statement is made or to reflect the occurrence of
unanticipated events. New factors emerge from time to time and it is not
possible for management to predict all of such factors, nor can it assess the
impact of each such factor on the business or the extent to which any factor,
or combination of factors, may cause actual results to differ materially from
those contained in any forward-looking statements.





                                       2
<PAGE>




ITEM 1.  FINANCIAL STATEMENTS


                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEET
                               September 30, 2003

<TABLE>
<CAPTION>
<S>                                                                                                           <C>
ASSETS
  CURRENT ASSETS
    Cash                                                                                                       $      1,947
    Inventory - real estate - residential units for sale - at cost                                                  917,083
    Prepaid expenses                                                                                                 10,841
                                                                                                               ------------
      Total Current Assets                                                                                          929,871
                                                                                                               ------------
DEPOSITS                                                                                                             35,000
                                                                                                               ------------
  ACCOUNT RECEIVABLE - related party                                                                                 57,264
                                                                                                               ------------
                                                                                                               $  1,022,135
                                                                                                               ============
LIABILITIES AND STOCKHOLDERS' EQUITY
  CURRENT LIABILITIES
    Notes payable - secured by residential units for sale                                                      $  1,041,513
    Accounts payable - related parties                                                                              260,740
    Accounts payable                                                                                                 45,507
                                                                                                               ------------
      Total Current Liabilities                                                                                   1,347,760
                                                                                                               ------------
MINORITY INTEREST                                                                                                       580
                                                                                                               ------------

STOCKHOLDERS'  DEFICIENCY
  Preferred stock
    10,000,000 shares authorized at $0.001 par value;
      1,000,000 shares issued and outstanding                                                                         1,000
  Common stock
    50,000,000 shares authorized at $0.001 par value;
      48,139,950 shares issued and outstanding                                                                       48,140
  Capital in excess of par value                                                                                    171,304
  Deficit accumulated during the development stage                                                                 (546,649)
                                                                                                               ------------
    Total Stockholders' Deficiency                                                                                 (326,205)
                                                                                                               ------------
    Total                                                                                                      $  1,022,135
                                                                                                               ============
</TABLE>


  The accompanying notes are an integral part of these financial statements.




                                      3
<PAGE>



                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
         For the Three and Nine Months Ended September 30, 2003 and 2002


<TABLE>
<CAPTION>
                                                                 Three Months                        Nine Months
                                                          ---------------------------        ---------------------------
                                                             Sept 30,       Sept 30,            Sept 30,      Sept 30,
                                                               2003           2002                2003          2002
                                                          -------------  ------------        -------------  ------------
<S>                                                        <C>              <C>               <C>               <C>
SALES                                                           271,679             -        $     634,868  $          -

COST OF SALES                                                   287,838             -              610,086             -
                                                          -------------  ------------        -------------  ------------
  Gross Profit                                                 (16,159)             -               24,782             -
                                                          -------------  ------------        -------------  ------------
EXPENSES
  Consultants                                                         -             -               90,000             -
  Administrative                                                  9,820        28,667               43,203        60,886
                                                          -------------  ------------        -------------  ------------
                                                                  9,820        28,667              133,203        60,886
                                                          -------------  ------------        -------------  ------------
NET LOSS - before minority interest                            (25,979)       (28,667)            (108,421)      (60,886)

LESS MINORITY INTEREST                                            (180)             -               (3,721)            -
                                                          -------------  ------------        -------------  ------------
NET LOSS                                                  $    (26,159)    $  (28,667)       $    (112,142)      (60,886)
                                                          =============  ============        =============  ============
NET LOSS PER COMMON SHARE
  Basic and diluted                                       $          -     $        -        $           -  $          -
                                                          -------------  ------------        -------------  ------------
AVERAGE  OUTSTANDING SHARES
  - (stated in 1,000's)
  Basic                                                          48,140        41,807               47,140        41,807
                                                          -------------  ------------        -------------  ------------
  Diluted                                                       345,140       341,807              345,140       341,807
                                                          -------------  ------------        -------------  ------------
</TABLE>

  The accompanying notes are an integral part of these financial statements.




                                      4
<PAGE>



                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                      CONSOLIDATED STATEMENT OF CASH FLOWS
              For the Nine Months Ended September 30, 2003 and 2002

<TABLE>
<CAPTION>
                                                              2003              2002
                                                          -------------     -------------
<S>                                                       <C>                <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                                $   (112,142)     $    (60,886)
    Adjustments to reconcile net loss to net cash
      provided by operating activities
    Changes in
      Inventory                                                439,135                 -
      Prepaid expenses                                          (4,441)                -
      Account receivable - related party                       (57,264)                -
      Accounts payable                                        (314,115)           60,886
    Minority interest                                            3,721                 -
                                                          -------------     -------------
      Net Cash from Operations                                 (45,106)                -
                                                          -------------     -------------
CASH FLOWS FROM INVESTING ACTIVITIES                                 -                 -
                                                          -------------     -------------
CASH FLOWS FROM FINANCING ACTIVITIES                                 -                 -
                                                          -------------     -------------
      Net Increase (decrease)  in Cash                         (45,106)                -

      Cash at Beginning of Period                               47,053                 -
                                                          -------------     -------------
      Cash at End of Period                               $      1,947      $          -
                                                          =============     =============
</TABLE>




  The accompanying notes are an integral part of these financial statements.





                                      5
<PAGE>



                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                          NOTES TO FINANCIAL STATEMENTS
                               September 30, 2003

1.                ORGANIZATION

The  Company  was  incorporated  under  the  laws of the  State of  Nevada  on
September 8, 1998 with the name of Mega International  Health Corporation with
authorized  common stock of  50,000,000  shares with a par value of $0.001 and
preferred stock of 10,000,000 shares with a par value of $0.001.  The terms of
the preferred includes conversion rights, at the option of stockholder, of 300
shares of common stock for each share of preferred.  On June 23, 1999 the name
was changed to Altrimega Health Corporation.

The Company was  organized for the purpose of marketing  nutritional  products
and during the year 2000 became  inactive.  During  November  2002 the Company
changed its purpose to the development and sale of residential  real estate by
the acquisition of a residential real estate development company.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ACCOUNTING METHODS

The Company  recognizes  income and  expenses  based on the accrual  method of
accounting.

DIVIDEND POLICY

The Company has not adopted a policy regarding payment of dividends.

INCOME TAXES

On September 30, 2003 the Company had a net  operating  loss  carryforward  of
$685,804.  The tax  benefit  of  approximately  $206,000  from the loss  carry
forward has been fully  offset by a valuation  reserve  because the use of the
future tax benefit is doubtful, since the Company has not been able to project
a  reliable  future net  operating  profit.  The loss  carryover  will  expire
starting in 2020 through 2024.

BASIC AND DILUTED NET INCOME (LOSS) PER SHARE

Basic net income (loss) per share  amounts are computed  based on the weighted
average number of shares actually  outstanding.  Diluted net income (loss) per
share amounts are computed using the weighted  average number of common shares
and common equivalent  shares  outstanding as if shares had been issued on the
exercise of the common share rights unless the exercise  becomes  antidilutive
and then only the basic per share amounts are shown in the report.

FINANCIAL INSTRUMENTS

The carrying amounts of financial instruments, including cash, inventory,
prepaid expense, an account receivable, and accounts payable, are considered by
management to be their estimated fair values.





                                      6
<PAGE>



                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                    NOTES TO FINANCIAL STATEMENTS (Continued)
                               September 30, 2003

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

FINANCIAL AND CONCENTRATIONS RISK

The Company does not have any  concentration or related financial credit risk,
except for an account receivable, which is considered to be fully collectable,
and inventory held for sale.

REVENUE RECOGNITION

Revenue is recognized on the sale and transfer of title to the residential
units.

STATEMENT OF CASH FLOWS

For the purposes of the  statement of cash flows,  the Company  considers  all
highly liquid  investments  with a maturity of three months or less to be cash
equivalents.

ADVERTISING AND MARKET DEVELOPMENT

The Company expenses advertising and market development costs as incurred.

PRINCIPALS OF CONSOLIDATION

The  consolidated  financial  statements  shown in this  report  excludes  the
historical operating  information of the parent before September 30, 2002, and
includes the operating information of the subsidiary,  Creative Holdings, Inc.
from July 3, 2002 (date of inception  of the  subsidiary),  and the  operating
information  of Sea Garden  Funding  LLC from  November  2002 (the date of the
purchase of 80% of the LLC).

All intercompany transactions have been eliminated.

ESTIMATES AND ASSUMPTIONS

Management uses estimates and assumptions in preparing financial statements in
accordance with accounting  principles generally accepted in the United States
of America. Those estimates and assumptions affect the reported amounts of the
assets and liabilities,  the disclosure of contingent  assets and liabilities,
and the reported  revenues and  expenses.  Actual  results could vary from the
estimates that were assumed in preparing these financial statements.

OTHER RECENT ACCOUNTING PRONOUNCEMENTS

The Company does not expect that the adoption of other recent accounting
pronouncements to have any material impact on its financial statements.



                                      7
<PAGE>



                  ALTRIMEGA HEALTH CORPORATION AND SUBSIDIARIES
                    NOTES TO FINANCIAL STATEMENTS (Continued)
                               September 30, 2003

3.  SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES

Officers-directors,  and their controlled  entities,  have acquired 36% of the
outstanding stock of the Company, after the conversion of the preferred shares
to common  shares  (note 1), and have made demand,  no interest,  loans to the
Company of $260,740.

The Company has made a demand,  no interest  loan,  to  the  minority  interest
holder of Sea Garden Funding LLC of $57,264.

The Company has an  employment  agreement  with an officer,  starting in 2003,
which  provides for an annual  salary of $100,000 with a 5% increase each year
to a maximum of  $125,000,  provided  the Company has a profit in the previous
year.

4.  CAPITAL STOCK

During 2002 the Company issued  10,500,000 common shares at $.02 for services,
and the stock issued for the acquisition of the subsidiary outlined in note 5.

On March 19, 2003  2,000,000  common  shares of the  Company  were issued as a
payment of $40,000 of accounts payable.

5.  ACQUISITION OF SUBSIDIARIES

On September  30, 2002 the Company  acquired all of the  outstanding  stock of
Creative Holding,  Inc.  (subsidiary),  by a stock for stock exchange in which
the former  stockholders  of Creative  received  13,619,950  common shares and
1,000,000  preferred  shares of the Company,  and after the  conversion of the
preferred  shares  to  common  shares,  (note  1)  represented  90.6%  of  the
outstanding stock of the company. For reporting purposes,  the acquisition was
treated as an acquisition of the Company by Creative  Holding,  Inc.  (reverse
acquisition) and a recapitalization  of Creative Holding,  Inc. The historical
financial  statements  prior  to  September  30,  2002 are  those of  Creative
Holding,  Inc. Creative Holding,  Inc. had no significant assets and therefore
no good will was recognized from the acquisition.  Creative Holdings, Inc. was
organized on July 3, 2002 in the state of South Carolina.

During November 2002 the Company acquired 80% of Sea Garden Funding LLC by the
assumption of certain liabilities. Sea Garden Funding LLC was organized in the
state  of  South  Carolina  on  November  13,  2002  for  the  purpose  of the
development and sale of residential real estate.

6.  GOING CONCERN

The  Company  will need  additional  working  capital  for its future  planned
activity  and to service  its debt which  raises  substantial  doubt about its
ability to continue as a going concern. Continuation of the Company as a going
concern  is  dependent  upon  obtaining   sufficient  working  capital  to  be
successful in that effort,  and the  management of the Company has developed a
strategy, which it believes will accomplish this objective, through additional
contributions to capital by related parties,  additional short term loans, and
equity funding, which should enable the Company to operate for the coming year.





                                      8
<PAGE>




ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION


PLAN OF OPERATION

         Altrimega has entered the real estate  development  business with its
merger with Creative  Holdings,  Inc. of Myrtle  Beach,  S.C.  Altrimega  will
strive to  locate,  evaluate  and  proceed  to finance  and  develop  multiple
projects  located  primarily in the Myrtle Beach,  S.C. area and the Carolinas
area of the United  States.  Management  believes that these areas provide the
population growth necessary to achieve profits from new construction projects.
For the last three years, Horry County, South Carolina has been one of the top
three fastest  growing  counties in the United States.  In 1997,  Horry County
showed a population of only 180,000. Based on current projections and the 2000
census data,  the county will have a permanent  population  of 500,000 by next
year. The principal  industries of the area are tourism related.  Myrtle Beach
is considered a drive-in  market,  where tourists will drive their cars rather
than  fly to the  destination.  The  tourism  industry  in  Myrtle  Beach  has
developed  three seasons,  spring golf,  summer beach vacations and fall golf.
The spring and fall golf seasons bring approximately 150,000 visitors per week
to play on the areas over 100 golf courses.  The summer vacation season brings
in approximately 400,000 per week. The average tourist stay is one week.

         Altrimega's business strategy includes a focus on interval ownership
properties that cater to this major tourism industry. As well, we intend to
develop projects in the medium price ranges for the areas permanent service
industry population. Management will attempt to seek out low-risk projects
throughout the Carolinas that do not require large financing commitments.


SEA GARDEN TOWN HOME COMMUNITY IN NORTH MYRTLE BEACH, SOUTH CAROLINA

         Altrimega has exercised Creative Holdings' option and acquired an 80%
interest in Sea Garden Funding,  LLC, the owner and developer of the remaining
59 units in a 175 unit, 2 bedroom, 2 bath town home community  approximately 3
blocks from the Atlantic  shoreline.  Sea Garden  Funding  purchased  the real
property from Sea Garden,  LLC on October 21, 2002 for the payment of $210,000
and the assumption of  $1,071,344.66 in mortgages on the real property held by
Horry  County State Bank.  The  development  consists of  buildings  that have
either 4 or 5 units per  building.  The  remaining  20% interest in Sea Garden
Funding,  LLC, is owned by an  unaffiliated  party.  The  community  currently
consists of 116 sold units.  This is Altrimega's  first revenue producing real
estate project. During the first three quarters of 2003, this project produced
revenue of $634,868 with gross profit of $24,782.


RESULTS OF OPERATIONS

         We are a development  stage  company and have had limited  operations
during the nine  months  ended  September  30, 2003 and during the fiscal year
ended  December  31,  2002.  Since our  inception  (September  8, 1998 through
September 30, 2003),  we have an  accumulated  deficit of $546,649 and we have
had limited operating capital.  As a result, the report of our auditor for the
fiscal year ended  December 31, 2002 contains a going  concern  qualification,
which  states  that  Altrimega  will need  additional  capital  for its future
planned  activities and to service its debt which raises  substantial  concern
about our ability to continue as a going concern.  Our continuation as a going
concern  is  dependent  on our  ability  to meet our  obligations  and  obtain
additional  debt or equity  financing  required until our current and proposed
real estate projects are generating  sufficient  earnings.  Until such time as
these projects are generating sufficient earnings, we have taken the following
steps to revise  our  operating  and  financial  requirements  in an effort to
enable us to continue in existence:

         o     We  have  reduced  administrative  expenses  to  a  minimum  by
               consolidating management  responsibilities to our president and
               chief executive officer.

         o     We intend to seek either equity or further debt funding.

         o     We will  attempt to obtain the  professional  services of third
               parties through favorable financing  arrangements or payment by
               the issuance of our common stock.

         We  believe  that the  foregoing  plan  will  enable  us to  generate
sufficient funds to continue its operations for the next twelve months.



                                      9
<PAGE>



         THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002


         REVENUE

         For the three months ended September 30, 2003,  Altrimega had revenue
of $271,679,  consisting of the sale of 3 units in the Sea Garden  Funding LLC
project.  During the three months ended  September 30, 2002,  Altrimega had no
revenue.


         COST OF  SALES

         For the three months ended  September 30, 2003, our cost of sales was
$287,838,  compared to $0 for the  comparable  period in the prior  year.  The
increase  of  $287,838  was the  result of sales of 3 units at the Sea  Garden
Funding LLC  project.  The sale of these units  resulted in a gross  profit of
($16,159) for the three months ended September 30, 2003, compared with a gross
profit of $0 for the  comparable  period in the prior year. The negative gross
profit was a result of the sale of higher cost units.


         EXPENSES

         For the three months ended  September  30, 2003,  Altrimega had total
expenses of $9,820,  consisting solely of administrative expenses.  During the
comparable  period in the prior year,  Altrimega had $28,667 in administrative
expenses.  The decrease in total  expenses of $18,847  during the three months
ended  September  30, 2003 was  primarily  due to our decrease in salaries and
legal and accounting fees.


         NET LOSS

         For the three months ended  September  30, 2003,  Altrimega had a net
loss of $26,159 as compared to a net loss of $28,667 for the comparable period
in the prior year. The decrease in our net loss was primarily  attributable to
decrease in  administrative  expenses for the three months ended September 30,
2003.  While  we had  revenues  during  the  third  quarter  of 2003  equaling
$271,679,  and no  revenues  during the third  quarter  of 2002,  our net loss
decrease only by $2,508 based on our negative  gross profit of $16,159 for the
three months ended September 30, 2003.


         NINE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002


         REVENUE

         For the nine months ended September 30, 2003,  Altrimega had revenues
of $634,868,  consisting of the sale of 7 units in the Sea Garden  Funding LLC
project.  During the nine months ended  September  30, 2002,  Altrimega had no
revenue.


         COST OF SALES

         For the nine months ended  September 30, 2003,  our cost of sales was
$610,086,  compared to $0 for the  comparable  period in the prior  year.  The
increase  of  $610,086  was the  result of sales of 7 units at the Sea  Garden
Funding LLC  project.  The sale of these units  resulted in a gross  profit of
$24,782 for the nine months ended  September  30, 2003,  compared with a gross
profit of $0 for the comparable period in the prior year.


         EXPENSES

         For the nine months ended  September  30, 2003,  Altrimega  had total
expenses of $133,203,  as compared to $60,886 for the comparable period in the
prior year. For the nine months ended September 30, 2003, Altrimega's expenses
consisted  of  $90,000  in  consulting  fees  and  $43,203  in  administrative
expenses,  as  compared  to  $60,886  in  administrative  expenses  during the
comparable  period  in the prior  year.  The  increase  in total  expenses  of
$72,317 or 118.8%,  was primarily due to consulting fees incurred in the nine
months ended September 30, 2003.


         NET LOSS

         For the nine months ended  September  30, 2003,  Altrimega  had a net
loss of  $112,142,  as compared  to a net loss of $60,886  for the  comparable
period in the prior year.  While we had revenues  during the nine months ended
September  30,


                                      10
<PAGE>


2003 equaling  $634,868 and no revenues during the nine months ended September
30, 2003,  our net loss  increased by $51,256  based on our increase for total
expenses during the nine months ended September 30, 2003.


LIQUIDITY AND CAPITAL RESOURCES

         We had limited  operations and no income during the fiscal year ended
December 31, 2002. We had limited  operations  during the first nine months of
2003. Our shortfall in working  capital,  which equaled  $417,889 at September
30, 2003, has been met through  advances from our president,  John Gandy,  and
other  shareholders  who have advanced  funds to pay expenses  incurred by the
Company  from  time to  time.  For the  remainder  of  fiscal  year  2003,  we
anticipate that we will need $300,000 to continue to fund basic operations, in
addition to funding necessary to acquire an develop real estate projects.

         For the nine months  ended  September  30,  2003,  we had revenues of
$634,868 and a net loss of $112,142.  On  September  30, 2003,  we had cash on
hand of $1,947, total assets of $964,871, total liabilities of $1,347,760, and
a working  capital deficit of $417,889.  Our accumulated  deficit at September
30, 2003 was $546,649.

         We anticipate  that we will require  significant  capital to maintain
our corporate  viability and execute our plan to develop real estate projects.
We  anticipate  necessary  funds will most likely be provided by our  existing
shareholders,  our  officers  and  directors  and outside  investors.  We will
require  significant loan guarantees to acquire properties for development and
to complete  construction on Creative  Holdings' planned projects.  We will be
required to pledge  equity in the Company to induce  individuals,  officers or
directors or other shareholders to guarantee our loans when necessary.

         Altrimega's  financial  statements  have  been  prepared  on a  going
concern basis that  contemplates  the realization of assets and the settlement
of liabilities  and  commitments in the normal course of business.  Management
recognizes that Altrimega must generate  additional  resources to enable it to
continue  operations.  Management  is  planning to obtain  additional  capital
principally through the sale of equity and debt securities. The realization of
assets and  satisfaction  of  liabilities  in the normal course of business is
dependent  upon  Altrimega  obtaining  additional  equity or debt  capital and
ultimately  obtaining  profitable  operations.  However,  no assurances can be
given that  Altrimega  will be successful in these  activities.  Should any of
these events not occur, the  accompanying  consolidated  financial  statements
will be materially affected.

         Altrimega  is at present  meeting  its current  obligations  from its
monthly cash flows, from investor capital and from loans from related parties.
However,  due  to  insufficient  cash  generated  from  operations,  Altrimega
currently  does not  internally  generated  cash  sufficient to pay all of its
incurred expenses and other liabilities.  As a result,  Altrimega is dependent
on investor capital and loans to meet its expenses and  obligations.  Although
investor  funds and related  party loans have  allowed  Altrimega  to meet its
obligations in the recent past,  there can be no assurances  that  Altrimega's
present  methods of  generating  cash flow will be  sufficient  to meet future
obligations.

         Net Cash used in operating activities was $45,106 for the nine months
period ended  September 30, 2003.  The cash was mainly used as a result of the
net loss of  $112,142  and the payment of accounts  payable of  $314,115,  and
offset  by the sale of  inventory  equaling  $439,135.  There was no cash from
investing  activities  or  financing  activities  during the nine months ended
September 30, 2003.

         From time to time,  Altrimega  may  evaluate  potential  acquisitions
involving  complementary   businesses,   content,  products  or  technologies.
Altrimega has no present  agreements or understanding with respect to any such
acquisition.  Altrimega's  future  capital  requirements  will  depend on many
factors,  including an increase in Altrimega's real estate projects, and other
factors including the results of future operations.


ITEM 3.  CONTROLS AND PROCEDURES

         (a)      Evaluation Of Disclosure Controls And Procedures:

         Within 90 days prior to the date of this report,  the Company carried
out an evaluation,  under the  supervision and with the  participation  of the
Company's  Principal Executive Officer and Principal Financial Officer, of the
effectiveness of the design and operation of the Company's disclosure controls
and procedures.  The Company's disclosure controls and procedures are designed
to  provide  a  reasonable  level of  assurance  of  achieving  the  Company's
disclosure control  objectives.  The Company's Principal Executive Officer and
Principal  Accounting  Officer have  concluded  that the Company's  disclosure
controls and procedures are, in fact,  effective at this reasonable  assurance
level.


                                      11
<PAGE>


         (b)      Changes In Internal Controls:

         There  were  no  significant  changes  in  the  Altrimega's  internal
controls or in other factors that could  significantly  affect these  controls
during the  quarter  covered by this  report or from the end of the  reporting
period to the date of this Form 10-QSB.






                                      12
<PAGE>




                           PART II: OTHER INFORMATION


ITEM 1.  LEGAL PROCEDURES

         None.


ITEM 2.  CHANGES IN SECURITIES

         (a) None.

         (b) None.

         (c) None.

         (d) None.


ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

         None.


ITEM 4.  SUBMISSION OF MATTERS TO BE A VOTE OF SECURITY HOLDERS

         None


ITEM 5.  OTHER INFORMATION

         None.


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         (a)(1) EXHIBITS. The following exhibits are included as part of this
report:


<TABLE>
<CAPTION>
EXHIBIT NUMBER                TITLE OF DOCUMENT                                LOCATION
-------------------------     ---------------------------------------------    -------------------------------------------
<S>                           <C>                                              <C>
2.01                          SHARE EXCHANGE AGREEMENT among Altrimega         Incorporated by reference to the Company's
                                Health Corporation, Creative Holdings, Inc.      report on Form 8-K, dated October 2, 2002
                                and the Shareholders of Creative Holdings,
                                Inc., dated as of September 2, 2002

4.01                          CERTIFICATE OF DESIGNATION AS OF SEPTEMBER 30,   Incorporated by reference to Exhibit 4.01
                                2002                                             to the Company's Form 10-KSB filed on May
                                                                                 20, 2003

31.1                          Certification by Chief Executive Officer         Provided herewith
                              pursuant to 15 U.S.C. Section 7241, as adopted
                              pursuant to Section 302 of the Sarbanes-Oxley
                              Act of 2002

31.2                          Certification by Chief Financial Officer         Provided herewith
                              pursuant to 15 U.S.C. Section 7241, as adopted
                              pursuant to Section 302 of the Sarbanes-Oxley
                              Act of 2002
</TABLE>




                                      13
<PAGE>

<TABLE>
<CAPTION>
EXHIBIT NUMBER                TITLE OF DOCUMENT                                LOCATION
-------------------------     ---------------------------------------------    -------------------------------------------
<S>                           <C>                                              <C>
32.1                          Certification by Chief Executive Officer         Provided herewith
                              pursuant to 18 U.S.C. Section 1350, as adopted
                              pursuant to Section 906 of the Sarbanes-Oxley
                              Act of 2002

32.2                          Certification by Chief Financial Officer         Provided herewith
                              pursuant to 18 U.S.C. Section 1350, as adopted
                              pursuant to Section 906 of the Sarbanes-Oxley
                              Act of 2002
</TABLE>


         (b) REPORTS ON FORM 8-K. None.





                                      14
<PAGE>



                                   SIGNATURES

         Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934,  the Company has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

November 18, 2003                   ALTRIMEGA HEALTH CORPORATION


                                    By:   /s/ John Gandy
                                       ---------------------------------------
                                          John Gandy,
                                          Chief Executive Officer and Director



                                    By:   /s/ Ron Hendrix
                                       ----------------------------------------
                                          Ron Hendrix,
                                          Chief Financial Officer and Secretary